Neurology® Podcast

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Brad Worrall & Dr. Bernadette Boden-Albala interview Dr. Amytis Towfighi from University of California at Los Angeles about her paper on midlife stroke surge among women in the U. S. The podcast concludes with Dr. Justin Sattin interviewing Dr. Kathryn S. Porter for the Lesson of the Week. Podcast participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Howard Hurtig and Dr. David A. Schoenfeld interview Dr. Beate Ritz from UCLA about her paper on nonsteroidal anti-inflammatory drugs. The podcast concludes with Dr. Lee I. Kubersky interviewing Dr. Carmel Armon for the Lesson of the Week. Podcast participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Blaise Bourgeois & Dr. Nathan Fountain interview Dr. Samuel Berkovic from the Epilepsy Research Center University of Melbourne, Australia about his paper studying the use of levetiracetam in patients with idiopathic generalized epilepsy. The podcast concludes with Dr. Andrew Tarulli interviewing Dr. Michael J. Lynn for the Lesson of the Week. Podcast participants had nothing to disclose except for Drs. Berkovic and Bourgeois. Dr. Berkovic has received grants in excess of $10,000 and honoraria not in excess of $10,000 from UCB Pharma SA, who were involved in the design and conduct of the study; collection, management, and analysis of the data; and preparation and review of the manuscript. Dr. Bourgeois has received grant support or consulting fees from Abbott, Eisai, Elan Pharmaceuticals, Ortho-McNeil, Novartis, Ovation Pharma, and UCB Pharma in excess of $10,000.The statements presented in this podcast do not necessarily reflect those of the American Academy of Neurology or the Editors of the Journal Neurology.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. John Sladky & Dr. Guillermo Solorzano interview Dr. Irving Nachamkin and Dr. Arthur Asbury from University of Pennsylvania School of Medicine about their paper on patterns of GBS in children. The podcast concludes with Dr. Michelle Mauerman interviewing Dr. Hugh Willison for the Lesson of the Week. Podcast participants have nothing to disclose. The statements presented in this podcast do not necessarily reflect those of the American Academy of Neurology or the Editors of the Journal Neurology.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Michael Benatar & Dr. Sung Bae Lee interview Dr. Jeffrey Cummings from UCLA about his paper on disease-modifying therapies for AD. The podcast concludes with Dr. John Carew interviewing Dr. Wiliam Jagust for the Lesson of the Week. Podcast participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Jeff Burns and Dr. John Morris interview Dr. Marson about his paper on mild cognitive impairment and medical decision-making. The podcast concludes with Dr. Daniel Press interviewing Dr. John Morris about mild cognitive impairment. Podcast participants had nothing to disclose except for Dr. Daniel Marson who received royalties from the UAB Research Foundation which owns the capacity outcome measure used in this study. The statements presented in this podcast do not necessarily reflect those of the American Academy of Neurology or the Editors of the Journal Neurology.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Mark Freedman & Dr. Ellis Hedaya interview Dr. Peter Calabresi from John Hopkins University about his paper on anti-natalizumab antibodies. The podcast concludes with Dr. Robb M. Snider interviewing Dr. James J. Lah for the Lesson of the Week. Podcast participants had nothing to disclose except for Dr. Peter Calabresi whohas received grant support in excess of $10,000 from Biogen Idec for other research/activities not reported in this article and honoraria from Biogen Idec in excess of $10,000/year. The statements presented in this podcast do not necessarily reflect those of the American Academy of Neurology or the Editors of the Journal Neurology.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Jim Kiely and Dr. Shanna Patterson interview Dr. Schiff about his paper on low-grade glioma. The podcast concludes with Dr. Lori Schuh interviewing Dr. Jennifer Quinn for the Lesson of the Week. Podcast participants had nothing to disclose except for Dr. David Schiff who has given lectures through the Schering-Plough Speaker's Bureau and served as a consultant to Schering-Plough.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Jim Galvin and Dr. Juliana Lockman interview Dr. Nikos Scarmeas from Columbia University about his paper on Alzheimer disease and the Mediterranean Diet. The podcast concludes with Dr. Ted Burns interviewing Dr. Gary Cutter for our first Lesson of the Week. Podcast participants had nothing to disclose.

This first Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief briefly discussing highlighted articles from the print issue of Neurology. In the second segment, Dr. Ted M. Burns and Dr. Karen Roos interview Dr. Frederick Blanc from France about his paper on antibody index testing for Lyme disease. The podcast concludes with Dr. Ted M. Burns providing an overview and background of the Neurology podcast initiative and an introduction to the podcast committee and other upcoming initiatives for future podcasts.